AlphaStocks
5.3
Consider Buy

Avantor, Inc. (AVTR)

As of Sep 20, 2026, Avantor, Inc. (AVTR) scores 5.3/10 on AlphaStocks' five-model composite, #95 of 168 Health Care stocks. At $16, AVTR trades 31% below its model fair value of $22.

Health Care / Life Sciences Tools & Services

S&P MidCap 400

$15.52

Below average on several measures. Research carefully.

Consider Buy

Score based on 4 of 5 models — moderate confidence

Data as of Sep 20, 2026

#95out of 168 in Health Care

Is Avantor, Inc. a Good Investment in 2026?

Avantor, Inc. (AVTR) scores 5.3 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates Avantor, Inc. as Attractive (6/9). However, the Greenblatt Magic Formula model rates it Caution — Earnings yield -2.3% · ROC -13%. Avantor, Inc. currently trades 31% below its estimated fair value of $22. Avantor, Inc. ranks #95 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

ROE-9.5Market Cap11B

Estimated Fair Value

$22.3831% below

Trading below estimated fair value.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

6/9

Buffett

Caution

Business quality & competitive moat

Graham

Caution

Price vs intrinsic value

Lynch

Attractive

Growth rate vs price (PEG)

Greenblatt

Caution

Earnings yield -2.3% · ROC -13%

Frequently Asked Questions

Is Avantor, Inc. (AVTR) a good investment?
As of Sep 20, 2026, Avantor, Inc. (AVTR) scores 5.3/10 on AlphaStocks' five-model composite, #95 of 168 Health Care stocks. At $16, AVTR trades 31% below its model fair value of $22. That score is below average, suggesting caution.
What is Avantor, Inc.'s Piotroski F-Score?
Avantor, Inc.'s Piotroski F-Score status is Attractive. The raw score is 6/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is AVTR overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $22, AVTR appears undervalued. The stock currently trades 31% below its estimated fair value. Trading below estimated fair value.
How does AVTR compare to other Health Care stocks?
Avantor, Inc. ranks #95 out of 168 stocks in the Health Care sector, placing it in the top 57% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about AVTR?
AlphaStocks evaluates AVTR using five proven investment models. Piotroski: Attractive; Buffett: Caution; Graham: Caution; Lynch: Attractive; Greenblatt Magic Formula: Caution. These models are combined into a single composite score of 5.3/10.

Similar Stocks

BIOILMNAZTA

Compare AVTR with

AVTR vs BIOAVTR vs ILMNAVTR vs AZTA

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer